Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Quarterly results
|
|
Axogen, Inc. (AXGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
4
| Burke William P. Mr. (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Bought 10,000 shares
@ $6.56, valued at
$65.6k
Granted 6,000 shares
@ $6.31, valued at
$37.9k
|
|
| 08/18/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/18/2023 |
8-K
| Quarterly results |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2023 |
SC 13G
| Soleus Capital Master Fund, L.P. reports a 8.2% stake in Axogen, Inc. |
| 08/10/2023 |
SC 13G/A
| ArrowMark Colorado Holdings LLC reports a 10.3% stake in Axogen, Inc. |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/07/2023 |
8-K
| Quarterly results |
| 07/24/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 07/07/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 06/30/2023 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S... |
| 06/05/2023 |
4
| Levine Alan M (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| JOHNSON JOHN (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| NEELS GUIDO J (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 12,500 shares
@ $8.65, valued at
$108.1k
Sold 29,480 shares
@ $8.74, valued at
$257.7k
Exercised 6,459 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| Wendell Amy McBride (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 06/05/2023 |
4
| THOMAS PAUL (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 6,459 restricted stock units
@ $0 |
|
| 06/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/24/2023 |
4
| Freitag Gregory Gene (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Sold 2,828 shares
@ $9.17, valued at
$25.9k
Sold 4,640 shares
@ $9.26, valued at
$43k
|
|
| 05/16/2023 |
4
| Wendell Amy McBride (Director) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 25,000 shares
@ $9.22, valued at
$230.5k
Exercised 3,750 shares
@ $9.22, valued at
$34.6k
Exercised 25,000 options to buy
@ $8.57, valued at
$214.3k
Exercised 3,750 options to buy
@ $8.57, valued at
$32.1k
|
|
| 05/09/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/09/2023 |
8-K
| Quarterly results |
| 05/01/2023 |
8-K
| Shareholder Nominations Pursuant to Exchange Act Rule 14a-11, Other Events Interactive Data |
| 05/01/2023 |
10-K/A
| Annual Report for the period ended December 31, 2022 [amend] |
| 03/20/2023 |
4
| MARTINEZ MARIA D. (Chief Human Resources Officer) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 933 shares
@ $8.27, valued at
$7.7k
Paid exercise price by delivering 389 shares
@ $8.27, valued at
$3.2k
Paid exercise price by delivering 1,358 shares
@ $8.27, valued at
$11.2k
Paid exercise price by delivering 1,590 shares
@ $8.27, valued at
$13.1k
Exercised 3,000 restricted stock units
@ $0
Exercised 1,250 restricted stock units
@ $0
Exercised 4,367 restricted stock units
@ $0
Exercised 5,900 restricted stock units
@ $0
Granted 66,500 options to buy
@ $8.27, valued at
$550k
Granted 46,300 options to buy
@ $0 |
|
| 03/20/2023 |
4
| Donovan Michael Patrick (VP Operations) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 934 shares
@ $8.27, valued at
$7.7k
Paid exercise price by delivering 1,835 shares
@ $8.27, valued at
$15.2k
Exercised 3,000 restricted stock units
@ $0
Exercised 5,900 restricted stock units
@ $0
Granted 63,500 options to buy
@ $8.27, valued at
$525.1k
Granted 48,500 restricted stock units
@ $0 |
|
| 03/20/2023 |
4
| DeVinney Erick Wayne (VP Peripheral Nerve Science) has filed a Form 4 on Axogen, Inc.|
Txns:
| Paid exercise price by delivering 1,835 shares
@ $8.27, valued at
$15.2k
Paid exercise price by delivering 934 shares
@ $8.27, valued at
$7.7k
Exercised 5,900 restricted stock units
@ $0
Exercised 3,000 restricted stock units
@ $0
Granted 64,000 options to buy
@ $8.27, valued at
$529.3k
Granted 46,300 restricted stock units
@ $0 |
|
| 03/20/2023 |
4
| Zaderej Karen L. (CEO) has filed a Form 4 on Axogen, Inc.|
Txns:
| Exercised 25,000 restricted stock units
@ $0
Exercised 12,975 restricted stock units
@ $0
Granted 179,000 options to buy
@ $8.27, valued at
$1.5M
Granted 112,000 restricted stock units
@ $0 |
|
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/14/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/14/2023 |
8-K
| Investor presentation |
|
|
|